Pharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation: a review
- 1 June 2006
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 4 (6) , 1180-1185
- https://doi.org/10.1111/j.1538-7836.2006.01890.x
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Resource Utilization and Costs of Stroke Unit Care in GermanyValue in Health, 2004
- Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complicationsPublished by Oxford University Press (OUP) ,2001
- Atrial Fibrillation and StrokeStroke, 2001
- Characteristics, Outcome, and Care of Stroke Associated With Atrial Fibrillation in EuropeStroke, 2001
- Resource Utilization and Costs of Stroke Unit Care Integrated in a Care Continuum: A 1-Year Controlled, Prospective, Randomized Study in Elderly PatientsStroke, 2000
- Acute Stroke With Atrial FibrillationStroke, 1996
- Clinically Important Drug Interactions with AnticoagulantsClinical Pharmacokinetics, 1996
- Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.BMJ, 1992
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991
- Physician variation in anticoagulating patients with atrial fibrillation. Dartmouth Primary Care COOP ProjectArchives of internal medicine (1960), 1990